These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29492960)

  • 21. Real-world determinants of adjunctive antipsychotic prescribing for patients with major depressive disorder and inadequate response to antidepressants: a case review study.
    McIntyre RS; Weiller E
    Adv Ther; 2015 May; 32(5):429-44. PubMed ID: 25968482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with Posttraumatic Stress Disorder with Comorbid Major Depressive Disorder Require a Higher Dose of Psychotropic Drugs.
    Chiba H; Oe M; Uchimura N
    Kurume Med J; 2016; 62(1-2):23-8. PubMed ID: 26935570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
    Fava M; Alpert JE; Carmin CN; Wisniewski SR; Trivedi MH; Biggs MM; Shores-Wilson K; Morgan D; Schwartz T; Balasubramani GK; Rush AJ
    Psychol Med; 2004 Oct; 34(7):1299-308. PubMed ID: 15697056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of aripiprazole for depressed patients with an inadequate response to antidepressant treatment: a 6-week prospective, open-label, multicenter study.
    Jon DI; Kim DH; Seo HJ; Kwon YJ; Kim MD; Yang JC; Suh HS; Min KJ; Pae CU; Bahk WM
    Clin Neuropharmacol; 2013; 36(5):157-61. PubMed ID: 24045606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of augmentation strategies for patients with major depressive disorder.
    Fleurence R; Williamson R; Jing Y; Kim E; Tran QV; Pikalov AS; Thase ME
    Psychopharmacol Bull; 2009; 42(3):57-90. PubMed ID: 19752841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Earley WR; Guo H; Németh G; Harsányi J; Thase ME
    Psychopharmacol Bull; 2018 Jun; 48(4):62-80. PubMed ID: 30618475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment.
    Garcia-Toro M; Medina E; Galan JL; Gonzalez MA; Maurino J
    BMC Psychiatry; 2012 Sep; 12():143. PubMed ID: 22988986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does a Positive Response to Lithium Augmentation in Resistant Major Depression Indicate a Bipolar Disorder?: A Long-Term Follow-up Study.
    Birkenhager TK; Shapiro-Koss C; Kamperman AM
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):202-204. PubMed ID: 33587395
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction of an Optimal Dose of Lamotrigine for Augmentation Therapy in Treatment-Resistant Depressive Disorder From Plasma Lamotrigine Concentration at Week 2.
    Nakamura A; Mihara K; Nagai G; Kagawa S; Suzuki T; Nemoto K; Kondo T
    Ther Drug Monit; 2016 Jun; 38(3):379-82. PubMed ID: 26829597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis.
    Perugi G; Pacchiarotti I; Mainardi C; Verdolini N; Menculini G; Barbuti M; Angst J; Azorin JM; Bowden CL; Mosolov S; Young AH; Vieta E;
    Eur Neuropsychopharmacol; 2019 Jul; 29(7):825-834. PubMed ID: 31227264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial.
    Mohamed S; Johnson GR; Sevilimedu V; Rao SD; Hicks PB; Chen P; Lauro K; Jurjus G; Pilkinton P; Davis L; Wilcox JA; Iranmanesh A; Sapra M; Aslam M; Michalets J; Thase M; Zisook S;
    J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32603560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder.
    Cha DS; Luo X; Ahmed J; Becirovic L; Cha RH; McIntyre RS
    Expert Rev Neurother; 2019 Sep; 19(9):777-783. PubMed ID: 31389279
    [No Abstract]   [Full Text] [Related]  

  • 38. Earlier Versus Later Augmentation with an Antipsychotic Medication in Patients with Major Depressive Disorder Demonstrating Inadequate Efficacy in Response to Antidepressants: A Retrospective Analysis of US Claims Data.
    Yermilov I; Greene M; Chang E; Hartry A; Yan T; Broder MS
    Adv Ther; 2018 Dec; 35(12):2138-2151. PubMed ID: 30456519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.
    Fava M; Okame T; Matsushima Y; Perry P; Weiller E; Baker RA
    Int J Neuropsychopharmacol; 2017 Jan; 20(1):22-30. PubMed ID: 27784751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.